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This special featured issue of Translational Stroke Research
gives readers a timely update on the emerging roles of gluta-
mate receptor-independent ion channels and transporters in
ischemic brain injury. This issue has collected contributions
from the leading research laboratories with expertise on the
most important ion transport targets. For example, Khanna
et al. [1] provide an overview on the significance of dysreg-
ulated ion homeostasis in the neurogliovascular unit in the
pathogenesis of ischemic cerebral edema, focusing on the role
of the sulfonylurea receptor 1-transient receptor potential
melastatin 4 (SUR1-TRPM4) channel complex which is up-
regulated in the context of hypoxia and promotes capillary
fragmentation and oncotic cell death in the vascular endothe-
lium, thereby increasing vascular permeability and vasogenic
edema. Song et al. write an elegant review on the distinct
changesofcellvolumehomeostasisinnecrotic,apoptotic,and
hybrid cell death that accompany ischemic stroke, along with
the N-methyl-D-aspartate-independent ion transporters and
channels that mediate apoptotic volume decrease or cytotoxic
cellswelling[2].Norenbergetal.[3]reportnovelmechanisms
underlying astrocyte swelling and brain edema mediated by
SUR1-TRPM4 activation in acute liver failure, extending
original findings by the Simard group in ischemic disease to
other types of brain swelling.
The second half of the issue include comprehensive dis-
cussions of voltage-gated K
+ channels [4] and the acid-
sensing ion channel 1a ASIC1a [5, 6] in ischemic neurotox-
icity, and voltage-gated H
+ channel Hv1 in microglial activa-
tion [7], following stroke. Uria-Avellanal et al. [8]p r e s e n t
compelling clinical and experimental research data on over-
stimulation of Na
+/H
+ exchangers and alkaline pHi in perina-
tal brain injury. Pignataro et al. discuss a strategy of targeting
increased Ca
2+ efflux mediated by Na
+/Ca
2+ exchanger in
stroke intervention [9]. Chen et al. review the significance of
ion channels in regulation of neuronal progenitor function in
ischemic brains, which holds the potential for tissue regener-
ation—an emerging area in the field of neuroprotection [10].
In summary, these timely papers illustrate exciting new
findings in the area of glutamate receptor-independent mech-
anisms of ischemic ionic injury in the nervous system, and
reveal the critical role of dysregulated ion transport, mediated
by diverse ion transport proteins, in the neurogliovascular
unit. These reports show that ischemia-induced ion channel/
transporter dysfunction affects multiple critical cell processes,
including cell volume regulation [11], intracellular ionic ho-
meostasis [12], neuroinflammation [13, 14], and
neuroregeneration/tissue repair [15, 16]. An increased under-
standing of the role these transport proteins play in normal
biology, along with further knowledge of how these proteins
are regulated by post-translational modification and signal
transduction, might reveal novel methods by which these
transport systems may be modulated for therapeutic benefit.
Perhaps nowhere closer is the reality of clinical translation
ofbasic findingsmoreapparentthaninthe story ofthe SUR1-
regulatedTRPM4ionchannel,andits roleinthe pathogenesis
of cerebral edema and hemorrhagic transformation following
ischemic stroke (see review by Khanna et al., in this issue).
Glibenclamide, an FDA-approved drug commonly used in
patients with type 2 diabetes, inhibits SUR1-TRPM4, and
several robust preclinical studies have demonstrated the
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DOI 10.1007/s12975-014-0324-3efficacy ofglibenclamide inreducing edema and hemorrhagic
conversion in rodent models of ischemic stroke. This has in
turn prompted the study of the potential protective effects of
glibenclamide in humans in an ongoing prospective phase II
clinical trial, and preliminary data from this effort suggests
glibenclamide also significantly reduces ischemic cerebral
edema and hemorrhagic conversion [17]. Many other targets
listed above are promising candidates at the cusp of human
translational studies. We are excited to present this timely
resource to the readers of Translational Stroke Research.
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